Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps "Mealtimes prove to be one of the biggest ...
With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn ...
The FDA approved Medtronic's latest MiniMed insulin pump system, the company announced late last week. Indicated for individuals with type 1 diabetes ages 7 and older, the MiniMed 780G system pairs ...
Late last week, medical device giant Medtronic received FDA approval for its MiniMed 780G system. The device is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved the Medtronic MiniMed 780G system for people with type 1 diabetes aged 7 years and older. The ...
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback